✦ LIBER ✦

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a New Class of Cannabinoid Receptor Agonists. Part 1. Discovery of CB2 Receptor Selective Compounds.

✍ Scribed by Hiroyuki Kai; et al. et al.

Publisher: John Wiley and Sons
Year: 2007
Weight: 19 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200746210

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

ChemInform Abstract: 2-Arylimino-5,6-dih

ChemInform Abstract: 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a New Class of Cannabinoid Receptor Agonists. Part 3. Synthesis and Activity of Isosteric Analogues.

✍ Hiroyuki Kai; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

Discovery of 1-(2,4-Dichlorophenyl)-4-et

Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist

✍ Ming-Shiu Hung; Chun-Ping Chang; Ting-Chieh Li; Teng-Kuang Yeh; Jen-Shin Song; Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyrid

2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a Novel Class of NR1/2B Subtype Selective NMDA Receptor Antagonists.

✍ Bernd Buettelmann; Alexander Alanine; Anne Bourson; Ramanjit Gill; Marie-Paule H 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 100 KB 👁 1 views

Stereoselective Synthesis of 5,6-Disubst

Stereoselective Synthesis of 5,6-Disubstituted-3,4-dihydro-1H-pyridin-2-ones, a New Class of Non-Biaryl Atropisomeric Compounds. Part 1.

✍ Ivan Jabin; Nicolas Monnier-Benoit; Stephane Le Gac; Pierre Netchitailo 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 100 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

ChemInform Abstract: Synthesis of Novel

ChemInform Abstract: Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M2 Muscarinic Receptor Antagonists. Part 2.

✍ T. WATANABE; A. KAKEFUDA; I. KINOYAMA; K. TAKIZAWA; S. HIRANO; H. SHIBATA; I. YA 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 2 views

Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M 2 Muscarinic Receptor Antagonists. Part 2. -Among the screened compounds derivative (IIIe) exhibits the highest affinity for M 2 muscarinic receptors and (III